Antitumor Immunity Can Be Uncoupled from Autoimmunity following Heat Shock Protein 70–Mediated Inflammatory Killing of Normal Pancreas

Timothy Kottke(Mayo Clinic in Arizona), Richard G. Vile(Mayo Clinic), Scott E. Strome(Northwestern Medicine Lake Forest Hospital), Jill Thompson(Mayo Clinic), Alan Melcher(University College Hospital), Stuart K. Calderwood(Beth Israel Deaconess Medical Center), Kevin J. Harrington(Royal Marsden NHS Foundation Trust), José S. Pulido(Wills Eye Hospital), Peter J. Selby(Centre for Addiction and Mental Health), Luis Sánchez-Pérez(Mayo Clinic), Heung Chong(St George's, University of London)
Cancer Research
September 9, 2009
10.1158/0008-5472.can-09-1597
Cited by 30

Related Papers

Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|5.1k
High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple Myeloma
|New England Journal of Medicine|2003|1.8k
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
|The Lancet|2018|1.7k
Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression
|Oral Oncology|2018|802